Evidence map›Paper›PMID 32255429›Full record

ArticleeLife2020

Evolution of multifunctionality through a pleiotropic substitution in the innate immune protein S100A9.

Joseph L Harman, Andrea N Loes, Gus D Warren, Maureen C Heaphy, Kirsten J Lampi, Michael J Harms

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Topiary: Pruning the manual labor from ancestral sequence reconstruction.Protein science : a publication of the Protein Society · 2023
    Article
  10. DecreasedPeerJ · 2023
    Article
  11. Review
  12. Evolutionary entrenchment in immune proteins selects against stabilizing mutations.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Evolution avoids a pathological stabilizing interaction in the immune protein S100A9.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joseph L HarmanDepartment of Chemistry and Biochemistry, University of Oregon, Eugene, United States.ORCID 0000-0002-8283-0301
Andrea N LoesDepartment of Chemistry and Biochemistry, University of Oregon, Eugene, United States.
Gus D WarrenDepartment of Chemistry and Biochemistry, University of Oregon, Eugene, United States.
Maureen C HeaphyDepartment of Chemistry and Biochemistry, University of Oregon, Eugene, United States.
Kirsten J LampiOregon Health & Science University, Portland, United States.
Michael J HarmsDepartment of Chemistry and Biochemistry, University of Oregon, Eugene, United States.ORCID 0000-0002-0241-4122
University of Oregon · USOregon Health & Science University · US

Funding

Graduate Training in Genetics Administrative Supplement - Career Curriculum DevelopmentT32GM007413 · NIGMS · UNIVERSITY OF OREGON · PI GUILLEMIN, KAREN J · 1985 to 2022
$7.8M
Supplement to: Molecular mechanisms for the evolution of the total peptide binding set in S100 proteinsR01GM117140 · NIGMS · UNIVERSITY OF OREGON · PI HARMS, MICHAEL JONATHAN · 2016 to 2020
$1.6M
NIGMS NIH HHS R01 GM117140NIGMS NIH HHS T32 GM007413NIH HHS 3R01GM117140-03S1
6 · The paper itself

Abstract

Multifunctional proteins are evolutionary puzzles: how do proteins evolve to satisfy multiple functional constraints? S100A9 is one such multifunctional protein. It potently amplifies inflammation via Toll-like receptor four and is antimicrobial as part of a heterocomplex with S100A8. These two functions are seemingly regulated by proteolysis: S100A9 is readily degraded, while S100A8/S100A9 is resistant. We take an evolutionary biochemical approach to show that S100A9 evolved both functions and lost proteolytic resistance from a weakly proinflammatory, proteolytically resistant amniote ancestor. We identify a historical substitution that has pleiotropic effects on S100A9 proinflammatory activity and proteolytic resistance but has little effect on S100A8/S100A9 antimicrobial activity. We thus propose that mammals evolved S100A8/S100A9 antimicrobial and S100A9 proinflammatory activities concomitantly with a proteolytic 'timer' to selectively regulate S100A9. This highlights how the same mutation can have pleiotropic effects on one functional state of a protein but not another, thus facilitating the evolution of multifunctionality.

Indexed as

Evolution, MolecularAnimalsCalgranulin ACalgranulin BHumansImmunity, InnateInflammationMammalsProteolysisToll-Like Receptor 4Calgranulin ACalgranulin BToll-Like Receptor 4ancestral sequence reconstructionantimicrobial activitybiochemistrychemical biologyevolutionary biologyinflammationmammalsnonepleiotropyprotein evolution

Identifiers

PMID32255429
PMCPMC7213983
OpenAlexW3014702047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.